http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104341362-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8be5426d28d133971ca0924ed527ea46
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06
filingDate 2014-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104341362-A
titleOfInvention Triazole sulfonyl malonate compound, its preparation method and use
abstract The invention relates to the field of medicines related to hyperuricemia and gout. Specifically, the present invention relates to a class of uric acid transporter 1 inhibitors containing a triazole sulfonyl malonate structure, a preparation method thereof, a pharmaceutical composition containing them and their application in the preparation of diabetes medicines. Wherein, R is selected from H, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109134391-A
priorityDate 2014-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103819419-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010135536-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010135530-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102186832-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467584650

Total number of triples: 17.